Showing results (351-360 of 378) with videos related to

Sort By:
Pageof 38
Nano Letters|September 25, 2015
Engineering Ultra-Low Work Function of GrapheneHongyuan Yuan, Shuai Chang, Igor Bargatin, et al.
Microsystems & Nanoengineering|October 23, 2019
Micron-gap spacers with ultrahigh thermal resistance and mechanical robustness for direct energy conversionSamuel M Nicaise, Chen Lin, Mohsen Azadi, et al.
Blood|January 30, 2015
Antigenic modulation limits the effector cell mechanisms employed by type I anti-CD20 monoclonal antibodiesThomas R W Tipton, Ali Roghanian, Robert J Oldham, et al.
The Journal of Biological Chemistry|June 19, 2007
Asparaginyl hydroxylation of the Notch ankyrin repeat domain by factor inhibiting hypoxia-inducible factorMathew L Coleman, Michael A McDonough, Kirsty S Hewitson, et al.
Current Biology : CB|July 16, 2013
Defensive bacteriome symbiont with a drastically reduced genomeAtsushi Nakabachi, Reiko Ueoka, Kenshiro Oshima, et al.
Scientific Reports|January 19, 2021
Analysis of insulin glulisine at the molecular level by X-ray crystallography and biophysical techniquesRichard B Gillis, Hodaya V Solomon, Lata Govada, et al.
The Journal of Biological Chemistry|June 4, 2002
Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural familyKirsty S Hewitson, Luke A McNeill, Madeline V Riordan, et al.
Human Reproduction (Oxford, England)|September 25, 2016
Novel circulating placental markers prokineticin-1, soluble fms-like tyrosine kinase-1, soluble endoglin and placental growth factor and association with late miscarriageC N Jayasena, A Abbara, A N Comninos, et al.
Blood|November 15, 2014
Upregulation of FcγRIIb on monocytes is necessary to promote the superagonist activity of TGN1412Khiyam Hussain, Chantal E Hargreaves, Ali Roghanian, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 18, 2018
The PI3Kδ-Selective Inhibitor Idelalisib Minimally Interferes with Immune Effector Function Mediated by Rituximab or Obinutuzumab and Significantly Augments B Cell Depletion In VivoAdam Palazzo, Sylvia Herter, Laura Grosmaire, et al.
Pageof 38